Premier Biomedical Stock Analysis
| BIEI Stock | USD 0.0009 0.0001 10.00% |
Premier Biomedical is overvalued with Real Value of 8.64E-4 and Hype Value of 0.001084. The main objective of Premier Biomedical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Premier Biomedical is worth, separate from its market price. There are two main types of Premier Biomedical's stock analysis: fundamental analysis and technical analysis.
The Premier Biomedical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Premier Biomedical's ongoing operational relationships across important fundamental and technical indicators.
Premier |
Premier Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Premier Biomedical last dividend was issued on the 27th of June 2018. The entity had 1:250 split on the 27th of June 2018. Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. Premier Biomedical is traded on OTC Exchange in the United States.The quote for Premier Biomedical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Premier Biomedical please contact the company at 724 633 7033 or go to https://www.premierbiomedical.com.Premier Biomedical Investment Alerts
| Premier Biomedical generated a negative expected return over the last 90 days | |
| Premier Biomedical has high historical volatility and very poor performance | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. |
Premier Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Premier Biomedical's market, we take the total number of its shares issued and multiply it by Premier Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Premier Biomedical holds the Coefficient Of Variation of (2,528), risk adjusted performance of (0.02), and Variance of 110.25. Premier Biomedical technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.Premier Biomedical Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Premier Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Premier Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Premier Biomedical Outstanding Bonds
Premier Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Premier Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Premier bonds can be classified according to their maturity, which is the date when Premier Biomedical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Premier Biomedical Predictive Daily Indicators
Premier Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Premier Biomedical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Premier Biomedical Forecast Models
Premier Biomedical's time-series forecasting models are one of many Premier Biomedical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Premier Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Premier Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Premier Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Premier shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Premier Biomedical. By using and applying Premier Pink Sheet analysis, traders can create a robust methodology for identifying Premier entry and exit points for their positions.
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. Premier Biomedical is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Premier Biomedical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Complementary Tools for Premier Pink Sheet analysis
When running Premier Biomedical's price analysis, check to measure Premier Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Premier Biomedical is operating at the current time. Most of Premier Biomedical's value examination focuses on studying past and present price action to predict the probability of Premier Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Premier Biomedical's price. Additionally, you may evaluate how the addition of Premier Biomedical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |